STEMdiff™ Hematopoietic Kit
For differentiation of human ES or iPS cells into hematopoietic progenitor cells
![STEMCELL Technologies Inc.](https://cdn.sanity.io/images/f5b6mtfn/selectscience-prod/238e63317b74fa81507bbcb1f5b40c7f78865bf6-300x75.jpg?w=256&q=75&fit=clip&auto=format)
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
STEMdiff™ Hematopoietic Kit includes a serum-free basal medium and supplements for the feeder-free differentiation of human embryonic stem (ES) and induced pluripotent stem (iPS) cells into hematopoietic progenitor cells expressing CD34, CD45, and CD43.
The simple, 12-day differentiation protocol is performed in two stages. During the first 3 days, STEMdiff™ Hematopoietic Supplement A is added to the basal medium to induce cells toward mesoderm. For the subsequent 9 days, mesodermal cells are further differentiated into hematopoietic progenitor cells using basal medium supplemented with STEMdiff™ Hematopoietic Supplement B. At the end of the 12-day protocol, hematopoietic cells can be easily harvested from the culture supernatant. This population typically contains 25 - 65% (average 43%) CD34+CD45+ progenitor cells, including progenitor cells that have the capacity to form hematopoietic colonies in the colony-forming unit (CFU) assay.
STEMdiff™ Hematopoietic Kit has been optimized for differentiation of cells maintained in mTeSR™1 (Catalog #85850) or TeSR™-E8™ (Catalog #05990).